CPT® Code 79403

1. Indications

This procedure is indicated for the treatment of specific malignancies, particularly those that express certain antigens targeted by the radiolabeled monoclonal antibodies. The following conditions are explicitly mentioned as indications for this therapy:

• Non-Hodgkin Lymphoma - A type of cancer that originates in the lymphatic system, characterized by the presence of malignant B-cell lymphocytes that express the CD20 antigen.

2. Procedure

The procedure for administering radiopharmaceutical therapy with radiolabeled monoclonal antibodies involves several critical steps to ensure safety and efficacy. Each step is outlined as follows:

• Step 1: Establishing IV Access - The first step in the procedure is to establish an intravenous access line. This is typically done by inserting a catheter into a suitable vein, allowing for the direct administration of the radiolabeled monoclonal antibody into the patient's bloodstream. Proper aseptic technique is essential during this step to prevent infection.
• Step 2: Administration of Radiolabeled Monoclonal Antibody - Once IV access is secured, the radiolabeled monoclonal antibody is prepared and administered through the IV line. The infusion is carefully monitored to ensure that the patient tolerates the treatment well. The radiolabeled antibody is designed to bind specifically to the target antigen on the cancer cells, facilitating targeted delivery of radiation.
• Step 3: Monitoring - After the administration of the radiopharmaceutical, the patient is monitored for any immediate adverse reactions or side effects. This monitoring is crucial to ensure patient safety and to manage any potential complications that may arise during or after the infusion.

3. Post-Procedure

Post-procedure care involves monitoring the patient for any delayed reactions to the therapy. Patients may experience side effects related to the infusion, such as fever, chills, or allergic reactions. It is important to provide supportive care as needed and to educate the patient about potential symptoms to watch for after the procedure. Additionally, follow-up appointments may be scheduled to assess the effectiveness of the treatment and to monitor for any long-term effects or complications associated with the therapy.